Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4+ T cells in the broncho-alveolar lavage of patients with systemic sclerosis-Reference-Cited by-同舟云学术

Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4+ T cells in the broncho-alveolar lavage of patients with systemic sclerosis

Published:2011-12 Issue:3 Volume:141 Page:293-303
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Divekar Anagha A.,Khanna Dinesh,Abtin Fereidoun,Maranian Paul,Saggar Rajeev,Saggar Rajan,Furst Daniel E.,Singh Ram Raj

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis;Atamas;Arthritis Rheum.,1999

2. Dual roles of IL-4 in lung injury and fibrosis;Huaux;J. Immunol.,2003

3. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N. Engl. J. Med.,2006

4. A benefit–risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours;Wolf;Drug Saf.,2009

5. Inhibition of c-fms by imatinib: expanding the spectrum of treatment;Dewar;Cell Cycle,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased Th1 Cells and Increased Th2 Cells in Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients with Interstitial Lung Disease;Inflammation;2022-10-20

2. Decreased Th1 Cells and Increased Th2 Cells In Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients With Interstitial Lung Disease;2022-09-06

3. Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis;Biomedicines;2022-01-29

4. Adaptive Immunity in Interstitial Lung Disease;Encyclopedia of Respiratory Medicine;2022

5. Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis;Expert Review of Clinical Immunology;2020-09-01